InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by GOLD DANIEL P PHD, Chairman & CEO. Insider active across 1 company, notably MEI Pharma, Inc.. Cumulatively, 4 disclosures have been recorded. Activity tracked since 25 May 2021. The latest transaction was filed on 2 July 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Daniel P. Gold, PhD, serves as the Chief Executive Officer of MEI Pharma, Inc. In this role, he oversees the company's operations and guides its strategy. His leadership is essential in ensuring growth and innovation within MEI Pharma.